1-(2-methoxyethyl)-1,2,3,4-tetrahydroquinolin-7-amine, 95.0%, 250mg

Di-tert-butyl 3,3'-azanediyldipropanoate, 97.0%, 5g

L-a-tert-Butylglycine-tert-butyl ester hydrochloride, 95.0%, 5g

(R)-5,7-Difluorochroman-4-ol, 97%, 100g

3-Acetylphenylboronic acid, 97.0%, 1g

HPLC column NUCLEODUR® NH2-RP 5 µm, 125 mm, 4 mm, 1 Piece(s)

1,4-Dihydro-benzo[d][1,3]oxazin-2-one, 95.0%, 5g

[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-7-CARBOXYLIC ACID, 95.0%, 5g

7-Fluoro-5-methoxy-2,3-dihydro-1H-inden-1-one, 97%, 250mg

(3S,4S)-TERT-BUTYL 3,4-DIHYDROXYPYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

tert-butyl 3-[(isobutoxycarbonyl)amino]piperidine-1-carboxylate, 250mg

2-Bromo-N-(2-(trifluoromethyl)phenyl)acetamide, 98%, 1g

2-(Pyridin-3-yl)-4,5-dihydrooxazole, 97.0%, 1g